Literature DB >> 26507497

Lung protective ventilation and hospital survival of cardiac intensive care patients.

M Schneck1, K Holder2, S Gielen2, S Nuding2, J Schröder2, A R Tamm2, K Werdan2, H Ebelt2.   

Abstract

OBJECTIVE: To detect connections between parameters of ventilation and outcomes of cardiac intensive care patients. DESIGN AND
SETTING: Noninterventional study. Between 05/11 and 05/12 all patients with acute heart failure and post cardiopulmonary resuscitation were registered. Lung protective ventilation was defined as peak inspiratory pressure (PIP) < 30 mmHg and tidal volume (Vt) < = 6 ml/kg.
RESULTS: In total, 129 patients were included in the study, 68.2 % male, age 67.9 ± 13.4 years, weight 71.4 ± 37.2 kg, predictive body weight 66.9 ± 8.8 kg, mortality 47.3 %. Lung protective ventilated patients at day 1: 17.3 % with a significant difference between surviving and nonsurviving patients (24.1 % vs. 9.6 %; p < 0.05). Logistic regression models showed a strong connection between PIP and survival (odds ratio 1.13; p < 0.05). Vt showed no significant influence on survival.
CONCLUSION: Our data recommends a strict observance of a low PIP for cardiac intensive care patients, whereas Vt seems to be of secondary importance.

Entities:  

Keywords:  Acute heart failure; Cardiopulmonary resuscitation; Lung protection; Lung protective ventilation; Peak inspiratory pressure; Tidal volume

Mesh:

Year:  2015        PMID: 26507497     DOI: 10.1007/s00063-015-0105-0

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  12 in total

1.  Characteristics and clinical outcome of 458 patients with acute myocardial infarction requiring mechanical ventilation. Results of the BEAT registry of the ALKK-study group.

Authors:  Kleopatra Kouraki; Steffen Schneider; Rainer Uebis; Ulrich Tebbe; Hermann H Klein; Uwe Janssens; Ralf Zahn; Jochen Senges; Uwe Zeymer
Journal:  Clin Res Cardiol       Date:  2010-09-29       Impact factor: 5.460

2.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.

Authors:  John J V McMurray; Stamatis Adamopoulos; Stefan D Anker; Angelo Auricchio; Michael Böhm; Kenneth Dickstein; Volkmar Falk; Gerasimos Filippatos; Cândida Fonseca; Miguel Angel Gomez-Sanchez; Tiny Jaarsma; Lars Køber; Gregory Y H Lip; Aldo Pietro Maggioni; Alexander Parkhomenko; Burkert M Pieske; Bogdan A Popescu; Per K Rønnevik; Frans H Rutten; Juerg Schwitter; Petar Seferovic; Janina Stepinska; Pedro T Trindade; Adriaan A Voors; Faiez Zannad; Andreas Zeiher
Journal:  Eur Heart J       Date:  2012-05-19       Impact factor: 29.983

3.  Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.

Authors:  Roy G Brower; Michael A Matthay; Alan Morris; David Schoenfeld; B Taylor Thompson; Arthur Wheeler
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

4.  Cardiogenic shock due to myocardial infarction: diagnosis, monitoring and treatment: a German-Austrian S3 Guideline.

Authors:  Karl Werdan; Martin Ruß; Michael Buerke; Georg Delle-Karth; Alexander Geppert; Friedrich A Schöndube
Journal:  Dtsch Arztebl Int       Date:  2012-05-11       Impact factor: 5.594

5.  Comparison of the SpO2/FIO2 ratio and the PaO2/FIO2 ratio in patients with acute lung injury or ARDS.

Authors:  Todd W Rice; Arthur P Wheeler; Gordon R Bernard; Douglas L Hayden; David A Schoenfeld; Lorraine B Ware
Journal:  Chest       Date:  2007-06-15       Impact factor: 9.410

Review 6.  [Lung protective ventilation in ARDS].

Authors:  I Biener; M Czaplik; J Bickenbach; R Rossaint
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-08-22       Impact factor: 0.840

7.  Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine (Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin (DIVI)).

Authors:  K Reinhart; F M Brunkhorst; H-G Bone; J Bardutzky; C-E Dempfle; H Forst; P Gastmeier; H Gerlach; M Gründling; S John; W Kern; G Kreymann; W Krüger; P Kujath; G Marggraf; J Martin; K Mayer; A Meier-Hellmann; M Oppert; C Putensen; M Quintel; M Ragaller; R Rossaint; H Seifert; C Spies; F Stüber; N Weiler; A Weimann; K Werdan; T Welte
Journal:  Ger Med Sci       Date:  2010-06-28

8.  Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study.

Authors:  Christian Brun-Buisson; Cosetta Minelli; Guido Bertolini; Luca Brazzi; Jorge Pimentel; Klaus Lewandowski; Julian Bion; Jacques-André Romand; Jesús Villar; Adalbjörn Thorsteinsson; Pierre Damas; Apostolos Armaganidis; François Lemaire
Journal:  Intensive Care Med       Date:  2003-10-16       Impact factor: 17.440

9.  Ventilator-associated lung injury in patients without acute lung injury at the onset of mechanical ventilation.

Authors:  Ognjen Gajic; Saqib I Dara; Jose L Mendez; Adebola O Adesanya; Emir Festic; Sean M Caples; Rimki Rana; Jennifer L St Sauver; James F Lymp; Bekele Afessa; Rolf D Hubmayr
Journal:  Crit Care Med       Date:  2004-09       Impact factor: 7.598

10.  Temporal trends in sudden cardiac arrest: a 25-year emergency medical services perspective.

Authors:  Thomas D Rea; Mickey S Eisenberg; Linda J Becker; John A Murray; Thomas Hearne
Journal:  Circulation       Date:  2003-05-19       Impact factor: 29.690

View more
  2 in total

1.  [Cardiogenic shock complicating myocardial infarction].

Authors:  Karl Werdan; Markus Wolfgang Ferrari; Roland Prondzinsky; Martin Ruß
Journal:  Herz       Date:  2022-01-11       Impact factor: 1.443

2.  Infarction-Related Cardiogenic Shock- Diagnosis, Monitoring and Therapy–A German-Austrian S3 Guideline.

Authors:  Karl Werdan; Michael Buerke; Alexander Geppert; Holger Thiele; Bernd Zwissler; Martin Ruß
Journal:  Dtsch Arztebl Int       Date:  2021-02-12       Impact factor: 5.594

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.